ARCHIVES

Mendelsohn Defends ImClone’s Actions And His Role In Development of C225

This article is from The Cancer Letter archive.

Vol. 28 No. 38 | October 18, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief: Coltman, Leb Lead ASCO, AACR; Young, Busch Presidents Elect; Renalda Hilkemeyer Honored

June 3, 1988

55 NCI Grantees Win Shannon Awards, NCI gets $5.2 Mil.

October 4, 1991

New Biologic Therapies Showing Promise In A Variety Of Advanced Solid Tumors

June 29, 2001

Zvi Fuks of Memorial Sloan-Kettering arrested and charged with securities fraud related to sale of ImClone stock.

March 11, 2005

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

Letter In Response To Hadley; RFA Available

July 7, 1995